Clinical Trial Update: Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study [Phase 4]

View source ↗

Summary

A phase 4 randomized trial comparing 2 days versus 5 days of octreotide after endoscopic therapy to prevent early rebleeding in esophageal varices.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Varices

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Tanta University | Conditions: Esophageal Varices | Phase 4 | Status: UNKNOWN